102 related articles for article (PubMed ID: 16149135)
21. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
[TBL] [Abstract][Full Text] [Related]
22. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
Kuang G; Huang AL; Tang N
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):440-2. PubMed ID: 15975279
[TBL] [Abstract][Full Text] [Related]
23. The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
Lin B; Morris DW; Chou JY
Biochemistry; 1997 Nov; 36(46):14096-106. PubMed ID: 9369482
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites.
Nolten LA; Steenbergh PH; Sussenbach JS
Mol Endocrinol; 1995 Nov; 9(11):1488-99. PubMed ID: 8584026
[TBL] [Abstract][Full Text] [Related]
25. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
26. HNF-3 beta, C/EBP beta, and HNF-4 act in synergy to enhance transcription of the human apolipoprotein B gene in intestinal cells.
Antes TJ; Levy-Wilson B
DNA Cell Biol; 2001 Feb; 20(2):67-74. PubMed ID: 11244563
[TBL] [Abstract][Full Text] [Related]
27. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.
Møldrup A; Ormandy C; Nagano M; Murthy K; Banville D; Tronche F; Kelly PA
Mol Endocrinol; 1996 Jun; 10(6):661-71. PubMed ID: 8776726
[TBL] [Abstract][Full Text] [Related]
28. Liver-enriched transcription factors, HNF-1, HNF-3, and C/EBP, are major contributors to the strong activity of the chicken CYP2H1 promoter in chick embryo hepatocytes.
Dogra SC; May BK
DNA Cell Biol; 1997 Dec; 16(12):1407-18. PubMed ID: 9428789
[TBL] [Abstract][Full Text] [Related]
29. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
31. Cytokine regulation of the liver transcription factor hepatocyte nuclear factor-3 beta is mediated by the C/EBP family and interferon regulatory factor 1.
Samadani U; Porcella A; Pani L; Johnson PF; Burch JB; Pine R; Costa RH
Cell Growth Differ; 1995 Jul; 6(7):879-90. PubMed ID: 7547510
[TBL] [Abstract][Full Text] [Related]
32. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
33. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.
Narayanan CS; Cui Y; Kumar S; Kumar A
Mol Cell Biochem; 2000 Sep; 212(1-2):81-90. PubMed ID: 11108139
[TBL] [Abstract][Full Text] [Related]
34. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
35. Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha.
Rodenburg RJ; Teertstra W; Holthuizen PE; Sussenbach JS
Mol Endocrinol; 1995 Apr; 9(4):424-34. PubMed ID: 7659086
[TBL] [Abstract][Full Text] [Related]
36. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice.
Mohr L; Yoon SK; Eastman SJ; Chu Q; Scheule RK; Scaglioni PP; Geissler M; Heintges T; Blum HE; Wands JR
Hum Gene Ther; 2001 May; 12(7):799-809. PubMed ID: 11339896
[TBL] [Abstract][Full Text] [Related]
37. [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].
Li DM; Li W; Tao M; Chen K; Gong FR; Xu ZK; Chen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):459-63. PubMed ID: 24034849
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
González S; López-Larrea C
J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
[TBL] [Abstract][Full Text] [Related]
39. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
[TBL] [Abstract][Full Text] [Related]
40. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
